News - Page 174 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article Mydecine Discovers Over 40 Groundbreaking Potential Pharmacologically Active Novel Compounds in Mushrooms

Mydecine Discovers Over 40 Groundbreaking Potential Pharmacologically Active Novel Compounds in Mushrooms

Post published:June 8, 2021
Post category:Press Release

Read more about the article Field Trip Health Ltd. Applies to List Its Common Shares on the NASDAQ Stock Market

Field Trip Health Ltd. Applies to List Its Common Shares on the NASDAQ Stock Market

Post published:June 8, 2021
Post category:Press Release

Read more about the article Psychedelic Bulletin: Poll Shows Support for Psilocybin in the UK; Psychedelics-tinged ETF Launches on NYSE; Patents Make Headlines

Psychedelic Bulletin: Poll Shows Support for Psilocybin in the UK; Psychedelics-tinged ETF Launches on NYSE; Patents Make Headlines

Post published:June 4, 2021
Post category:Psychedelic Bulletin

Read more about the article Delix Therapeutics Announces Scientific & Strategic Advisory Board Appointments

Delix Therapeutics Announces Scientific & Strategic Advisory Board Appointments

Post published:June 4, 2021
Post category:Press Release

Read more about the article Op-ed: UK Public Support Psilocybin Research & Rescheduling Despite Government Stance

Op-ed: UK Public Support Psilocybin Research & Rescheduling Despite Government Stance

Post published:June 4, 2021
Post category:News Op-ed

Read more about the article COMPASS Pathways and Kings College London publish cognition results from COMP360 psilocybin study in healthy volunteers

COMPASS Pathways and Kings College London publish cognition results from COMP360 psilocybin study in healthy volunteers

Post published:June 3, 2021
Post category:Press Release

Read more about the article Mindset Selects its Lead Clinical Candidate, MSP-1014, a Next Generation Psychedelic Medicine

Mindset Selects its Lead Clinical Candidate, MSP-1014, a Next Generation Psychedelic Medicine

Post published:June 3, 2021
Post category:Press Release

Read more about the article Field Trip Health Ltd. to Commence Trading on the Toronto Stock Exchange on June 7, 2021

Field Trip Health Ltd. to Commence Trading on the Toronto Stock Exchange on June 7, 2021

Post published:June 3, 2021
Post category:Press Release

Read more about the article MINDCURE Successfully Completes First Stage of Manufacturing Synthetic Ibogaine for Use in Psychedelic Clinical Research

MINDCURE Successfully Completes First Stage of Manufacturing Synthetic Ibogaine for Use in Psychedelic Clinical Research

Post published:June 3, 2021
Post category:Press Release

Read more about the article MEC Announces Submission of Listing Statement to the CSE in Coordination with Albert Labs RTO

MEC Announces Submission of Listing Statement to the CSE in Coordination with Albert Labs RTO

Post published:June 3, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.